Early reduction in PD-L1 expression predicts faster treatment response in human cutaneous leishmaniasis
J Clin Invest
.
2024 Mar 1;134(5):e180162.
doi: 10.1172/JCI180162.
Authors
Nidhi S Dey
,
Sujai Senaratne
,
Vijani Somaratne
,
Nayani P Madarasinghe
,
Bimalka Seneviratne
,
Sarah Forrester
,
Marcela Montes de Oca
,
Luiza Campos Reis
,
Srija Moulik
,
Pegine B Walrad
,
Mitali Chatterjee
,
Hiro Goto
,
Renu Wickremasinghe
,
Dimitris Lagos
,
Paul M Kaye
,
Shalindra Ranasinghe
PMID:
38426499
PMCID:
PMC10904038
DOI:
10.1172/JCI180162
No abstract available
MeSH terms
B7-H1 Antigen / genetics
B7-H1 Antigen / metabolism
Humans
Leishmaniasis, Cutaneous* / drug therapy
Skin Neoplasms* / metabolism
Substances
B7-H1 Antigen